Skip to main content

Table 3 Tumor histopathology with the demonstration of the number (No.) and percentage (%) for each type

From: Role of fused PET/CT compared to the standard contrast-enhanced CT in the follow-up assessment of the treated gastric malignancy

Histopathology type

No. of patients

% of patients

Adenocarcinoma

50 patients

73.5%

Lymphoma

16 patients

23.5%

Carcinoid

2 patients

3%